Search results
Results from the WOW.Com Content Network
Brain Research Bulletin is a peer-reviewed scientific journal covering neuroscience. It was established in 1976 with Matthew J. Wayner (then at Syracuse University ) as founding editor in chief . Later it was edited by Stephen Dunnett ( Cardiff University ).
[1] [2] The goal of the IBNS is to "encourage research and education in the field of behavioral neuroscience". Its current president is Mikhail Pletnikov. Brain Research Bulletin, [3] Neuroscience and Biobehavioral Reviews, [4] and Physiology and Behavior [5] are official journals of the IBNS.
Behavioral Neuroscience (journal) Behavioural Brain Research; Behavioural Pharmacology (journal) Biological Psychiatry (journal) Biological Psychology (journal) Brain (journal) Brain and Behavior; Brain and Cognition; Brain and Neuroscience Advances; Brain, Behavior, and Immunity; Brain Research; Brain Research Bulletin; Brain Structure and ...
Brain Research is a peer-reviewed scientific journal focusing on several aspects of neuroscience. It publishes research reports and " minireviews ". The editor-in-chief is Matthew J. LaVoie ( University of Florida ).
A number of online neuroscience databases are available which provide information regarding gene expression, neurons, macroscopic brain structure, and neurological or psychiatric disorders. Some databases contain descriptive and numerical data, some to brain function, others offer access to 'raw' imaging data, such as postmortem brain sections ...
He and his team found that those who spent more time on social media were “significantly” more likely to feel angry or annoyed. For example, those who said they used social media “most of ...
Brain Research Bulletin; Brain Stimulation (journal) The Breast (journal) British Accounting Review; British Journal of Anaesthesia; C. Cancer Epidemiology (journal)
MRZ-9547, also known as (R)-phenylpiracetam, (R)-phenotropil, or (R)-fonturacetam, is a selective dopamine reuptake inhibitor (IC 50 Tooltip half-maximal inhibitory concentration = 14.5 μM) that was developed by Merz Pharma.